NRX Pharmaceuticals- Warrants (24/05/2026) Total Liabilities

As of the most recent data (June 2026), NRXPW shows a total liabilities of $34M. That compares with $40M in the prior-year period — down 15.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NRXPW's total liabilities is now $34M (was $40M) — a 15.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NRX Pharmaceuticals- Warrants (24/05/2026) is outperforming or lagging.

Tracking NRXPW's total liabilities over time shows whether NRX Pharmaceuticals- Warrants (24/05/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $34M That compares with $40M in the prior-year period — down 15.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has NRX Pharmaceuticals- Warrants (24/05/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $34M) with ownership activity and broader fundamentals.

NRX Pharmaceuticals- Warrants (24/05/2026)'s total liabilities is $34M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.